Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children

PHASE4RecruitingINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

October 6, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment
Interventions
DRUG

intravenous immunoglobulin

To compare the efficacy of two different dosage regimens of intravenous immune globulin (IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia

Trial Locations (1)

350001

RECRUITING

Children with newly dignosed ITP, Fuzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Xiamen University

OTHER

collaborator

Zhangzhou Affiliated Hospital of Fujian Medical University

OTHER

collaborator

Quanzhou First Hospital

OTHER

collaborator

Nanping First Hospital Affiliated to Fujian Medical University

UNKNOWN

collaborator

The Second Hospital of Anhui Medical University

OTHER

collaborator

The Affiliated Hospital Of Guizhou Medical University

OTHER

collaborator

Longyan City First Hospital

OTHER

collaborator

The Affiliated Hospital of Putian University

OTHER

lead

Fujian Medical University Union Hospital

OTHER